Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 214

1.

Novel therapies for severe dyslipidemia originating from human genetics.

Gaudet D.

Curr Opin Lipidol. 2016 Feb 4. [Epub ahead of print]

PMID:
26849851
2.

Association between a polymorphic poly-T repeat sequence in the promoter of the somatostatin gene and hypertension.

Tremblay M, Brisson D, Gaudet D.

Hypertens Res. 2016 Jan 28. doi: 10.1038/hr.2016.4. [Epub ahead of print]

PMID:
26818653
3.

Gene-based therapies in lipidology: current status and future challenges.

Gaudet D, Brisson D.

Curr Opin Lipidol. 2015 Dec;26(6):553-65. doi: 10.1097/MOL.0000000000000240.

PMID:
26780008
4.

Efficacy and safety of rosuvastatin therapy in children and adolescents with familial hypercholesterolemia: Results from the CHARON study.

Braamskamp MJ, Langslet G, McCrindle BW, Cassiman D, Francis GA, Gagné C, Gaudet D, Morrison KM, Wiegman A, Turner T, Kusters DM, Miller E, Raichlen JS, Wissmar J, Martin PD, Stein EA, Kastelein JJ.

J Clin Lipidol. 2015 Nov-Dec;9(6):741-50. doi: 10.1016/j.jacl.2015.07.011. Epub 2015 Aug 1.

PMID:
26687694
5.

Dietary Vitamin A and Visceral Adiposity: A Modulating Role of the Retinol-Binding Protein 4 Gene.

Goodwin K, Abrahamowicz M, Leonard G, Perron M, Richer L, Veillette S, Gaudet D, Paus T, Pausova Z.

J Nutrigenet Nutrigenomics. 2015 Dec 15;8(4-6):164-173. [Epub ahead of print]

PMID:
26667887
6.

Influence of Abdominal Obesity on the Lipid-Lipoprotein Profile in Apoprotein E2/4 Carriers: The Effect of an Apparent Duality.

Villeneuve S, Brisson D, Gaudet D.

J Lipids. 2015;2015:742408. doi: 10.1155/2015/742408. Epub 2015 Oct 28.

7.

LRP1B, BRD2 and CACNA1D: new candidate genes in fetal metabolic programming of newborns exposed to maternal hyperglycemia.

Houde AA, Ruchat SM, Allard C, Baillargeon JP, St-Pierre J, Perron P, Gaudet D, Brisson D, Hivert MF, Bouchard L.

Epigenomics. 2015 Oct;7(7):1111-22. doi: 10.2217/epi.15.72. Epub 2015 Nov 20.

PMID:
26586120
8.

Issues Affecting Quality of Life and Disease Burden in Lipoprotein Lipase Deficiency (Lpld) - First Step Towards a Pro Measure in Lpld.

Johnson C, Stroes ES, Soran H, Wierzbicki A, Moulin P, Bruckert E, Steinhagen-Thiessen E, Gaudet D, Iotti G, Rastelletti I, Ossenkoppele B, Dippel M, Leclerc M, Averna M.

Value Health. 2015 Nov;18(7):A707. doi: 10.1016/j.jval.2015.09.2658. Epub 2015 Oct 20. No abstract available.

PMID:
26533960
9.

Hospitalizations In Hyperchylomicronemia Patients In Quebec, Canada; Results From A Real-World Observational Study.

Lachaine J, Gaudet D, Miron A, Tremblay K.

Value Health. 2015 Nov;18(7):A679. doi: 10.1016/j.jval.2015.09.2018. Epub 2015 Oct 20. No abstract available.

PMID:
26533807
10.

Visceral fat enhances blood pressure reactivity to physical but not mental challenges in male adolescents.

Van Woudenberg M, Abrahamowicz M, Leonard G, Perron M, Richer L, Veillette S, Gaudet D, Paus T, Pausova Z.

Pediatr Obes. 2015 Oct;10(5):395-402. doi: 10.1111/ijpo.12068.

PMID:
26364941
11.

Development of a real-time immuno-PCR assay for the quantification of 17β-estradiol in water.

Gaudet D, Nilsson D, Lohr T, Sheedy C.

J Environ Sci Health B. 2015;50(10):683-90. doi: 10.1080/03601234.2015.1048097.

PMID:
26273752
12.

Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia.

Gaudet D, Alexander VJ, Baker BF, Brisson D, Tremblay K, Singleton W, Geary RS, Hughes SG, Viney NJ, Graham MJ, Crooke RM, Witztum JL, Brunzell JD, Kastelein JJ.

N Engl J Med. 2015 Jul 30;373(5):438-47. doi: 10.1056/NEJMoa1400283.

13.

Layered genetic control of DNA methylation and gene expression: a locus of multiple sclerosis in healthy individuals.

Shin J, Bourdon C, Bernard M, Wilson MD, Reischl E, Waldenberger M, Ruggeri B, Schumann G, Desrivieres S, Leemans A; IMAGEN Consortium; SYS Consortium, Abrahamowicz M, Leonard G, Richer L, Bouchard L, Gaudet D, Paus T, Pausova Z.

Hum Mol Genet. 2015 Oct 15;24(20):5733-45. doi: 10.1093/hmg/ddv294. Epub 2015 Jul 28.

PMID:
26220975
14.

Alirocumab as Add-On to Atorvastatin Versus Other Lipid Treatment Strategies: ODYSSEY OPTIONS I Randomized Trial.

Bays H, Gaudet D, Weiss R, Ruiz JL, Watts GF, Gouni-Berthold I, Robinson J, Zhao J, Hanotin C, Donahue S.

J Clin Endocrinol Metab. 2015 Aug;100(8):3140-8. doi: 10.1210/jc.2015-1520. Epub 2015 Jun 1.

15.

The effect of an apolipoprotein A-I-containing high-density lipoprotein-mimetic particle (CER-001) on carotid artery wall thickness in patients with homozygous familial hypercholesterolemia: The Modifying Orphan Disease Evaluation (MODE) study.

Hovingh GK, Smits LP, Stefanutti C, Soran H, Kwok S, de Graaf J, Gaudet D, Keyserling CH, Klepp H, Frick J, Paolini JF, Dasseux JL, Kastelein JJ, Stroes ES.

Am Heart J. 2015 May;169(5):736-742.e1. doi: 10.1016/j.ahj.2015.01.008. Epub 2015 Jan 28.

PMID:
25965722
16.

Association of age-dependent height and bone mineral density decline with increased arterial stiffness and rate of fractures in hypertensive individuals.

El-Bikai R, Tahir MR, Tremblay J, Joffres M, Šeda O, Šedová L, Awadalla P, Laberge C, Knoppers BM, Dumas P, Gaudet D, Ste-Marie LG, Hamet P.

J Hypertens. 2015 Apr;33(4):727-35; discussion 735. doi: 10.1097/HJH.0000000000000475.

PMID:
25915877
17.

The lipid-lowering effects of lomitapide are unaffected by adjunctive apheresis in patients with homozygous familial hypercholesterolaemia - a post-hoc analysis of a Phase 3, single-arm, open-label trial.

Stefanutti C, Blom DJ, Averna MR, Meagher EA, Theron Hd, Marais AD, Hegele RA, Sirtori CR, Shah PK, Gaudet D, Vigna GB, Sachais BS, Di Giacomo S, du Plessis AM, Bloedon LT, Balser J, Rader DJ, Cuchel M; Phase 3 HoFH Lomitapide Study Investigators.

Atherosclerosis. 2015 Jun;240(2):408-14. doi: 10.1016/j.atherosclerosis.2015.03.014. Epub 2015 Mar 14.

18.

The changing boundaries of nursing: a qualitative study of the transition to a new nursing care delivery model.

Rhéaume A, Dionne S, Gaudet D, Allain M, Belliveau E, Boudreau L, Brown L.

J Clin Nurs. 2015 Sep;24(17-18):2529-37. doi: 10.1111/jocn.12846. Epub 2015 Apr 20.

PMID:
25892431
19.

Effect of the DGAT1 inhibitor pradigastat on triglyceride and apoB48 levels in patients with familial chylomicronemia syndrome.

Meyers CD, Tremblay K, Amer A, Chen J, Jiang L, Gaudet D.

Lipids Health Dis. 2015 Feb 18;14:8. doi: 10.1186/s12944-015-0006-5.

20.

CYP17A1 and Blood Pressure Reactivity to Stress in Adolescence.

Van Woudenberg M, Shin J, Bernard M, Syme C, Abrahamowicz M, Leonard G, Perron M, Richer L, Veillette S, Gaudet D, Paus T, Pausova Z.

Int J Hypertens. 2015;2015:734586. doi: 10.1155/2015/734586. Epub 2015 Jan 26.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk